v3.26.1
Derivatives
6 Months Ended
Jun. 30, 2026
Derivatives  
Derivatives

9.   Derivatives.

General. Our earnings and cash flows are subject to fluctuations due to changes in interest rates and foreign currency exchange rates, and we seek to mitigate a portion of the risks attributable to those fluctuations by entering into derivative contracts. The derivative instruments we use are foreign currency forward contracts. We recognize derivative instruments as either assets or liabilities at fair value in the accompanying consolidated balance sheets, regardless of whether hedge accounting is applied. We report cash flows arising from our hedging instruments consistent with the classification of cash flows from the underlying hedged items. Accordingly, cash flows associated with our derivative contracts are classified as operating activities in the accompanying consolidated statements of cash flows.

We formally document, designate and assess the effectiveness of transactions that receive hedge accounting treatment initially and on an ongoing basis. For qualifying hedges, the change in fair value is deferred in accumulated other comprehensive income, a component of stockholders’ equity in the accompanying consolidated balance sheets, and recognized in earnings at the same time the hedged item affects earnings. Changes in the fair value of derivative instruments not designated as hedging instruments are recorded in earnings throughout the term of the derivative.

Foreign Currency Risk. We operate on a global basis and are exposed to the risk that our financial condition, results of operations, and cash flows could be adversely affected by changes in foreign currency exchange rates. To reduce the potential effects of foreign currency exchange rate movements on net earnings, we enter into derivative financial instruments in the form of foreign currency exchange forward contracts with major financial institutions. Our policy is to enter into foreign currency derivative contracts with maturities of up to two years. We are exposed to foreign currency exchange rate risk with respect to transactions and balances denominated in various currencies, with our most significant exposure related to transactions and balances denominated in Chinese Renminbi and Euros, among others. We do not use derivative financial instruments for trading or speculative purposes. We do not believe we are subject to any credit risk contingent features related to our derivative contracts, and we seek to manage counterparty risk by allocating derivative contracts among several major financial institutions.

Derivatives Designated as Cash Flow Hedges

For derivative instruments that are designated and qualify as cash flow hedges, the gain or loss on the derivative instrument is temporarily reported as a component of other comprehensive income and then reclassified into earnings in the same line item associated with the forecasted transaction and in the same period or periods during which the hedged transaction affects earnings. We entered into forward contracts on various foreign currencies to manage the risk associated with forecasted exchange rates which impact revenues, cost of sales, and operating expenses in various international markets. The objective of the forward contracts is to reduce the variability of cash flows associated with the forecasted purchase or sale of the foreign currencies. As of June 30, 2026 and December 31, 2025, we had entered into foreign currency forward contracts, which qualified as cash flow hedges, with aggregate notional amounts of $127.1 million and $138.6 million, respectively.

Derivatives Not Designated as Cash Flow Hedges

We forecast our net exposure in various receivables and payables to fluctuations in the value of various currencies, and we enter into foreign currency forward contracts to mitigate a portion of that exposure. As of June 30, 2026 and December 31, 2025, we had entered into foreign currency forward contracts related to those balance sheet accounts with aggregate notional amounts of $139.7 million and $107.6 million, respectively.

Balance Sheet Presentation of Derivative Instruments. As of June 30, 2026 and December 31, 2025, all derivative instruments, both those designated as hedging instruments and those that were not designated as hedging instruments, were recorded at fair value on a gross basis on our consolidated balance sheets. We are not subject to any master netting agreements.

The fair value of derivative instruments on a gross basis was as follows on the dates indicated (in thousands):

Fair Value of Derivative Instruments Designated as Hedging Instruments

 

Balance Sheet Location

  ​ ​ ​

June 30, 2026

  ​ ​ ​

December 31, 2025

Assets

 

  ​

 

  ​

 

  ​

Foreign currency forward contracts

 

Prepaid expenses and other assets

$

3,445

$

3,555

Foreign currency forward contracts

 

Other assets (long-term)

352

 

663

(Liabilities)

 

  ​

 

  ​

 

  ​

Foreign currency forward contracts

 

Accrued expenses

 

(2,082)

 

(2,183)

Foreign currency forward contracts

 

Other long-term obligations

 

(168)

 

(424)

Fair Value of Derivative Instruments Not Designated as Hedging Instruments

 

Balance Sheet Location

  ​ ​ ​

June 30, 2026

  ​ ​ ​

December 31, 2025

Assets

 

  ​

 

  ​

 

  ​

Foreign currency forward contracts

 

Prepaid expenses and other assets

$

2,147

$

1,390

(Liabilities)

 

  ​

 

  ​

 

  ​

Foreign currency forward contracts

 

Accrued expenses

 

(1,967)

 

(1,620)

Income Statement Presentation of Derivative Instruments.

Derivative Instruments Designated as Cash Flow Hedges

Derivative instruments designated as cash flow hedges had the following effects, before income taxes, on other comprehensive income (“OCI”), accumulated other comprehensive income (“AOCI”), and net earnings in our consolidated statements of income, consolidated statements of comprehensive income and consolidated balance sheets (in thousands):

Amount of Gain/(Loss)

Consolidated Statements

Amount of Gain/(Loss)

Recognized in OCI

of Income

Reclassified from AOCI

Three Months Ended June 30, 

 

  ​

Three Months Ended June 30, 

Three Months Ended June 30, 

Derivative instrument

  ​ ​ ​

2026

 

2025

  ​ ​ ​

Location in statements of income

  ​ ​ ​

2026

  ​

  ​

2025

  ​

2026

  ​

  ​

2025

Foreign currency forward contracts

$

732

$

(1,396)

Revenue

$

418,843

$

382,462

$

(643)

$

509

Cost of sales

 

(203,677)

 

(197,975)

 

1,040

 

(242)

Amount of Gain/(Loss)

Consolidated Statements

Amount of Gain/(Loss)

Recognized in OCI

of Income

Reclassified from AOCI

Six Months Ended June 30, 

  ​

Six Months Ended June 30, 

Six Months Ended June 30, 

  ​ ​ ​

Derivative instrument

  ​ ​ ​

2026

 

2025

  ​ ​ ​

Location in statements of income

  ​ ​ ​

2026

 

2025

  ​

2026

 

 

2025

 

Foreign currency forward contracts

$

590

$

(3,293)

Revenue

$

800,720

$

737,813

$

(1,160)

$

1,530

Cost of sales

 

(400,757)

 

(381,306)

 

1,955

 

(774)

As of June 30, 2026, a gain of $1.9 million, or $1.4 million after taxes, was expected to be reclassified from AOCI to earnings in revenue and cost of sales over the succeeding twelve months.

Derivative Instruments Not Designated as Hedging Instruments

The following gains/(losses) from these derivative instruments were recognized in our consolidated statements of income for the periods presented (in thousands):

  ​ ​ ​

  ​ ​ ​

Three Months Ended June 30, 

  ​ ​ ​

Six Months Ended June 30, 

Derivative Instrument

 

Location in statements of income

 

2026

 

2025

 

2026

 

2025

Foreign currency forward contracts

 

Other income (expense) — net

$

(1,753)

$

1,340

$

(3,441)

$

1,182